Genomic rearrangements of the human MYB gene and mutations that create de-novo MYB binding sites in transcriptional control regions of the TAL1 and LMO1 oncogenes have been detected in acute lymphoid leukemia, suggesting that MYB plays causal roles in the development of these leukemias8–10. Here, MYB is linked to acute lymphoblastic leukemia.